These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28238680)

  • 1. Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil.
    Sakata H; Kuroki H; Ouchi K; Tajima T; Iwata S;
    J Infect Chemother; 2017 May; 23(5):307-311. PubMed ID: 28238680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of 3-day tebipenem pivoxil therapy in children with community-acquired pneumonia.
    Sakata H
    Jpn J Antibiot; 2016 Sep; 69(3):125-130. PubMed ID: 30226948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of safety and efficacy of tebipenem pivoxil granules for pediatric in pneumonia, otitis media and sinusitis].
    Kataoka H; Kasahara H; Sasagawa Y; Matsumoto M; Shimada S
    Jpn J Antibiot; 2016 Feb; 69(1):53-76. PubMed ID: 27290830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
    Eckburg PB; Muir L; Critchley IA; Walpole S; Kwak H; Phelan AM; Moore G; Jain A; Keutzer T; Dane A; Melnick D; Talley AK
    N Engl J Med; 2022 Apr; 386(14):1327-1338. PubMed ID: 35388666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tebipenem pivoxil hydrobromide on the normal gut microbiota of a healthy adult population in Sweden: a randomised controlled trial.
    Sewunet T; Razavi M; Rosenborg S; Camporeale A; Nowak M; Melnick D; Gasink LB; Eckburg PB; Critchley IA; Nord CE; Giske CG
    Lancet Microbe; 2024 Apr; 5(4):e355-e365. PubMed ID: 38432233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.
    Coelho L; Póvoa P; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H
    Crit Care; 2007; 11(4):R92. PubMed ID: 17723153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin pharmacokinetic profile and efficacy evaluation in empiric treatment of community-acquired pneumonia.
    Öbrink-Hansen K; Hardlei TF; Brock B; Jensen-Fangel S; Kragh Thomsen M; Petersen E; Kreilgaard M
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2398-404. PubMed ID: 25666151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    Sakata H
    Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia in children.
    McIntosh K
    N Engl J Med; 2002 Feb; 346(6):429-37. PubMed ID: 11832532
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tebipenem pivoxil hydrobromide-No PICC, no problem!
    Sodhi V; Kronsberg KA; Clark M; Cho JC
    Pharmacotherapy; 2021 Sep; 41(9):748-761. PubMed ID: 34370326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing antibiotics for community acquired pneumonia.
    Mehta PN
    Indian Pediatr; 2003 Oct; 40(10):958-64. PubMed ID: 14581733
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children].
    Ouchi K; Sunakawa K
    Jpn J Antibiot; 2014 Jun; 67(3):157-66. PubMed ID: 25163249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in children: guidelines for treatment.
    Nelson JD
    Pediatr Infect Dis J; 2000 Mar; 19(3):251-3. PubMed ID: 10749470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Community-acquired pneumonia in a child].
    Korppi M
    Duodecim; 2010; 126(9):1065-70. PubMed ID: 20593629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IV Penicillin G is as effective as IV cefuroxime in treating community-acquired pneumonia in children.
    Amarilyo G; Glatstein M; Alper A; Scolnik D; Lavie M; Schneebaum N; Grisaru-Soen G; Assia A; Ben-Sira L; Reif S
    Am J Ther; 2014; 21(2):81-4. PubMed ID: 22407197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pneumonia-causing pathogenic organisms in children and the usefulness of tebipenem pivoxil for their treatment.
    Kuroki H; Tateno N; Ikeda H; Saito N
    J Infect Chemother; 2010 Aug; 16(4):280-7. PubMed ID: 20352278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide for the diagnosis and treatment of pediatric pneumonia.
    Jadavji T; Law B; Lebel MH; Kennedy WA; Gold R; Wang EE
    CMAJ; 1997 Mar; 156(5):S703-11. PubMed ID: 9068582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.